+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Diagnostics Market by Technology (Flow Cytometry, Imaging, Immunohistochemistry), Cancer Type (Hematological Cancers, Solid Tumors), End User - Global Forecast 2025-2030- Product Image
Cancer Diagnostics Market by Technology (Flow Cytometry, Imaging, Immunohistochemistry), Cancer Type (Hematological Cancers, Solid Tumors), End User - Global Forecast 2025-2030- Product Image
Sale

Cancer Diagnostics Market by Technology (Flow Cytometry, Imaging, Immunohistochemistry), Cancer Type (Hematological Cancers, Solid Tumors), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011653
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cancer diagnostics market is undergoing significant transformation, shaped by the convergence of diverse technologies, increasing global cooperation, and a heightened focus on early detection and precision medicine. Senior decision-makers require clear, actionable intelligence to navigate this rapidly evolving ecosystem and align organizational strategy for sustained growth and resilience.

Market Snapshot: Cancer Diagnostics Market Growth Drivers

The cancer diagnostics market grew from USD 33.31 billion in 2024 to USD 37.32 billion in 2025. It is expected to continue growing at a CAGR of 11.82%, reaching USD 65.14 billion by 2030. This expansion is driven by unified innovation across imaging, molecular profiling, cytometry, and digital health, enabling earlier detection and individualized care. Rapid technology integration and collaboration among industry stakeholders are reshaping value propositions and clinical pathways globally.

Cancer Diagnostics Market Scope & Segmentation

  • Technology: Flow cytometry, imaging modalities, immunohistochemistry, in situ hybridization, and molecular diagnostics.
  • Technological Segments: Includes cell sorting, multiparameter flow cytometry, computed tomography, MRI, PET, ultrasound, chromogenic and fluorescent applications, microarray, PCR, and sequencing platforms.
  • Cancer Types: Hematological cancers (leukemia, lymphoma, multiple myeloma) and solid tumors (breast, colorectal, lung, prostate).
  • End User: Ambulatory care, diagnostic laboratories, hospitals, research institutes (academic and private).
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and multiple others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Key Companies Monitored: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, QIAGEN N.V., Sysmex Corporation, Illumina Inc., bioMérieux SA, Siemens Healthineers AG, Agilent Technologies Inc.

Key Takeaways for Senior Decision-Makers

  • Technology convergence across major diagnostic modalities is fast-tracking access to personalized oncology solutions and supporting more robust clinical decision-making frameworks.
  • Strategic partnerships between diagnostic companies, academic institutions, and technology innovators are critical to accelerating product development and shortening time-to-market.
  • Regional nuances—including differences in regulatory requirements, reimbursement structures, and healthcare infrastructure—require a flexible approach to market entry and expansion.
  • Adoption of patient-centric models, such as telehealth and at-home sample collection, is increasing market reach and reducing geographic disparities in care access.
  • Evolving business models, including modular laboratory setups and cloud-enabled reporting, support greater flexibility, scalability, and customer-centric service delivery.

Tariff Impact on Cancer Diagnostic Supply Chains

New U.S. tariff schedules introduced in 2025 have affected cross-border cancer diagnostic supply chains, prompting manufacturers to modify sourcing strategies, invest in nearshoring, and shift supplier agreements to balance increased costs. These adjustments have spurred broader investments in automation and regional manufacturing, strengthening supply chain resilience and encouraging greater vertical integration. Stakeholder collaboration and proactive regulatory engagement are essential for sustaining innovation pipelines and maintaining market access during trade disruptions.

Methodology & Data Sources

This report leverages a comprehensive approach, combining extensive secondary research—including peer-reviewed literature, regulatory filings, and market analyses—with primary interviews of clinicians, laboratory managers, and industry experts. Quantitative surveys and expert validation sessions underpin findings, while rigorous data triangulation and quality control ensure high integrity and actionable insight.

Why This Report Matters

  • Enables executives to anticipate regulatory shifts, technological disruption, and clinical adoption trends in a complex landscape.
  • Supports tailored investment strategies through detailed segmentation across technology, cancer type, end user, and regional markets.
  • Provides comparative tracking of leading industry players and evolving business models for more effective competitive benchmarking.

Conclusion

The cancer diagnostics market is experiencing dynamic evolution, providing ample opportunity for strategy-driven growth. Organizations that leverage this data-rich intelligence will be best positioned to deliver innovative diagnostic solutions and meet emerging global healthcare needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms for early cancer detection and risk stratification
5.2. Adoption of liquid biopsy tests for minimally invasive monitoring of tumor dynamics and treatment response
5.3. Expansion of companion diagnostics for personalized oncology therapies driven by genomic profiling data
5.4. Implementation of multiomics approaches combining proteomics and metabolomics for comprehensive tumor profiling
5.5. Growth of decentralized point-of-care cancer screening platforms enabling remote patient access and early intervention
5.6. Regulatory approvals and reimbursement expansions accelerating access to next-generation sequencing in oncology diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.2.1. Cell Sorting
8.2.2. Multiparameter Flow Cytometry
8.3. Imaging
8.3.1. Computed Tomography
8.3.2. Magnetic Resonance Imaging
8.3.3. Positron Emission Tomography
8.3.4. Ultrasound
8.4. Immunohistochemistry
8.4.1. Chromogenic
8.4.2. Fluorescent
8.5. In Situ Hybridization
8.6. Molecular Diagnostics
8.6.1. Microarray
8.6.2. Pcr
8.6.3. Sequencing
9. Cancer Diagnostics Market, by Cancer Type
9.1. Introduction
9.2. Hematological Cancers
9.2.1. Leukemia
9.2.2. Lymphoma
9.2.3. Multiple Myeloma
9.3. Solid Tumors
9.3.1. Breast Cancer
9.3.2. Colorectal Cancer
9.3.3. Lung Cancer
9.3.4. Prostate Cancer
10. Cancer Diagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Care
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
10.5.1. Academic Institutes
10.5.2. Private Research Centers
11. Americas Cancer Diagnostics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Cancer Diagnostics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Cancer Diagnostics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. F. Hoffmann-La Roche Ltd
14.3.2. Abbott Laboratories
14.3.3. Thermo Fisher Scientific Inc.
14.3.4. Danaher Corporation
14.3.5. QIAGEN N.V.
14.3.6. Sysmex Corporation
14.3.7. Illumina, Inc.
14.3.8. bioMérieux SA
14.3.9. Siemens Healthineers AG
14.3.10. Agilent Technologies, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 22. CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 23. CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 24. CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CELL SORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY PRIVATE RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 138. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 139. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 140. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 141. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 142. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 143. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 148. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 149. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 150. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 151. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 154. CANADA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 257. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 260. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 261. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 262. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 277. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 280. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 281. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 282. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 283. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 284. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 317. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 320. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 321. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 322. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 323. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2024 (USD MILLION)
TABLE 324. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2025-2030 (USD MILLION)
TABLE 325. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 326. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 327. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 328. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 329. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2018-2024 (USD MILLION)
TABLE 330. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY HEMATOLOGICAL CANCERS, 2025-2030 (USD MILLION)
TABLE 331. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 332. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 333. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 336. ITALY CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 337. SPAIN CANCER DIAGNOSTICS MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • Sysmex Corporation
  • Illumina, Inc.
  • bioMérieux SA
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 37.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 65.14 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Head & Neck Cancer Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Flow Cytometry, Fluorescence In Situ Hybridization, Imaging Technology), End User, Application, Cancer Type - Global Forecast 2025-2030 - Product Image

Head & Neck Cancer Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Services), Technology (Flow Cytometry, Fluorescence In Situ Hybridization, Imaging Technology), End User, Application, Cancer Type - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests, Imaging Tests, Molecular Tests), By End-use (Hospitals And Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests, Imaging Tests, Molecular Tests), By End-use (Hospitals And Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Coverage, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.